Hypofractionation for Soft Tissue Sarcoma
Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.
Category
- Hypofractionation
- Sarcoma
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Neoadjuvant Immunotherapy in Head and Neck Cancer, Sarcoma and Cutaneous Malignancies
Recent landmark studies in melanoma, cutaneous squamous cell carcinoma (cSCC), head and neck cancer (HNC) and sarcoma have established neoadjuvant immune therapy as a potential standard of care for patients with locally advanced cancers.
Category
- Head and Neck
- Immunotherapy
- Sarcoma
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Radiation for Non-Spine Bone Metastases
This presentation reviews the role of radiation therapy in the management of non-spine bone metastases, focusing on patient evaluation, treatment intent, dose selection, and integration with systemic and surgical care.
Category
- Palliative Care
- Sarcoma
- SBRT
Format
- Sessions onDemand
Credits
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Certificate of Attendance
Cost $149.00
Current Approaches to Management of Bone Sarcomas in Adolescent and Young Adult (AYA) Patients
Bone sarcomas are routinely diagnosed in the adolescent and young adult population.
Category
- Sarcoma
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
New Tools for Formidable Foes: Strategies for Management of Unresected Soft Tissue Sarcomas
Some patients with soft tissue sarcomas may be inoperable due to medical comorbidity or might decline radical or amputative surgeries due to undesirable functional outcomes.
Category
- Sarcoma
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Retroperitoneal sarcomas (RPS), a rare subset of soft tissue sarcomas, account for 10-15% of these cases and are distinguished by their substantial size, infiltrative nature, and proximity to vital anatomical structures.
Category
- Sarcoma
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00

Facebook
X
LinkedIn
Forward